PMV Pharmaceuticals, Inc. (PMVP) Tops Q3 EPS by 12c

PMV Pharmaceuticals, Inc. (NASDAQ: PMVP) reported Q3 EPS of ($0.34), $0.12 better than the analyst estimate of ($0.46).

For earnings history and earnings-related data on PMV Pharmaceuticals, Inc. (PMVP) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M